DO WE NEED TO SCREEN OUR PATIENTS FOR EBV IGG ANTIBODY BEFORE KIDNEY TRANSPLAN TATION?

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

BELADI MOUSAVI SEYED SEYF ELAH; HAYATI F.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Nephro-Urology Monthly Year:2011 | Volume:3 | Issue:2 Page(s): 122-124

Download Full-Text

View:

475

Download:

Cites:

Information Journal Paper

Title

DO WE NEED TO SCREEN OUR PATIENTS FOR EBV IGG ANTIBODY BEFORE KIDNEY TRANSPLAN TATION?

Author(s)

BELADI MOUSAVI SEYED SEYF ELAH | HAYATI F. | Issue Writer Certificate

Keywords

RENAL TRANSPLANTATION

ANTIBODIES

IGG

IGM

Abstract

Background: Epstein-Barr virus (EBV) can cause serious complications in kidney transplant patients. Current guidelines are recommended that both recipients and donors, be routinely tested for EBV IGG antibody before kidney transplantation.Objectives: The aim of the study was to evaluate the value of this recommendation. Patients and Methods: In a cross sectional study from February 2009 to March 2010, we evaluat ed donors and recipients who referred to our kidney transplant center. Routine pretransplante laboratory testes including EBV IGG and IGM antibody were performed. Results: A total of 112 people, 52 donors (29 male and 23 Female) and 60 recipients (38 male and 22 female) were included in the study. Mean age of donors and recipients were 31.3±6.7 years and 42.1 ± 12.57 years, respectively. Marker of HBV and HCV infections were positive in only 1 and 2 recipients and negative in all of donors. EBV IGG antibody was positive in 70 percent of recipi ents (n = 42) and 52 percent of donors (n = 27) but there was no statistically significant differ ence between them (p = 0 .053) and between males and females (p = 0.94). EBV IGM antibody was negative in 97 percent of recipients (n = 57) and 100 percent of donors (n = 67). Conclusion: The seroprevalence of EBV infection among candidate for kidney transplantation in khuzestan is not very high compared to other provinces in Iran, although we should perform screening for EBV to avoid kidney donation from seropositive donor to seronegative recipient.

Cites

No record.

References

No record.

Cite

APA: Copy

BELADI MOUSAVI, SEYED SEYF ELAH, & HAYATI, F.. (2011). DO WE NEED TO SCREEN OUR PATIENTS FOR EBV IGG ANTIBODY BEFORE KIDNEY TRANSPLAN TATION?. THE JOURNAL OF NEPHRO-UROLOGY MONTHLY, 3(2), 122-124. SID. https://sid.ir/paper/323670/en

Vancouver: Copy

BELADI MOUSAVI SEYED SEYF ELAH, HAYATI F.. DO WE NEED TO SCREEN OUR PATIENTS FOR EBV IGG ANTIBODY BEFORE KIDNEY TRANSPLAN TATION?. THE JOURNAL OF NEPHRO-UROLOGY MONTHLY[Internet]. 2011;3(2):122-124. Available from: https://sid.ir/paper/323670/en

IEEE: Copy

SEYED SEYF ELAH BELADI MOUSAVI, and F. HAYATI, “DO WE NEED TO SCREEN OUR PATIENTS FOR EBV IGG ANTIBODY BEFORE KIDNEY TRANSPLAN TATION?,” THE JOURNAL OF NEPHRO-UROLOGY MONTHLY, vol. 3, no. 2, pp. 122–124, 2011, [Online]. Available: https://sid.ir/paper/323670/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops